Determination of oxycodone and its metabolite, noroxycodone, in human plasma by HPLC with post-column chemiluminescence detection using electrogenerated tris(2,2′-bipyridyl)ruthenium(III)

Journal of Liquid Chromatography and Related Technologies

Volumn 27, Issue 10, 2004, Pages 1611-1626

  Gemba, Yukako ^a   Konishi, Masaharu ^a   Sakata, Takako ^a   Okabayashi, Yoshito ^a  

^a SHIONOGI AND CO LTD   (Japan)

Author keywords

Human plasma; Noroxycodone; Oxycodone; Post column chemiluminescence

Indexed keywords

ALCOHOLS; ASSAYS; BODY FLUIDS; METABOLISM; PH EFFECTS; SPECTROPHOTOMETRY;

HUMAN PLASMA; QUANTITATION;

HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

BUFFER; DODECYL SULFATE SODIUM; DRUG METABOLITE; METHANOL; NOROXYCODONE; OXYCODONE; PHOSPHATE; RUTHENIUM DERIVATIVE; TRIS(2,2' BIPYRIDYL)RUTHENIUM; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; BLOOD SAMPLING; CALIBRATION; CANCER PATIENT; CONCENTRATION (PARAMETERS); CONTROLLED DRUG RELEASE; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG RESEARCH; ELECTRICITY; EXTRACTION; FREEZING; HUMAN; QUANTITATIVE ANALYSIS; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ROOM TEMPERATURE; TEMPERATURE DEPENDENCE; THAWING; VALIDATION PROCESS;

EID: 2942556753     PISSN: 10826076     EISSN: None     Source Type: Journal    
DOI: 10.1081/JLC-120034095     Document Type: Article

References (18)

1. Kalso, E.; Vainio, A. Morphine and oxycodone hydrochloride in the management of cancer pain. Clin. Pharmacol. Ther. 1990, 47, 639-646.
2. Pöyhiä, R.; Olkkola, K.T.; Seppälä, T.; Kalso, E. The pharmacokinetics of oxycodone after intravenous injection in adults. Br. J. Clin. Pharmac. 1991, 32, 516-518.
3. Leow, K.P.; Smith, M.T.; Williams, B.; Cramond, T. Single-dose and steady-state pharmacokinetics and pharmacodynamics of oxycodone in patients with cancer. Clin. Pharmacol. Ther. 1992, 52, 487-495.
4. Pöyhiä, R.; Vainio, A.; Kalso, E. A review of oxycodone's clinical pharmacokinetics and pharmacodynamics. J. Pain Symptom Manage. 1993, 8, 63-67.
5. Beaver, W.T.; Wallenstein, S.L.; Rogers, A.; Houde, R.W. Analgesic studies of codeine and oxycodone in patients with cancer. II. Comparisons of intramuscular oxycodone with intramuscular morphine and codeine. J. Pharmacol. Exp. Ther. 1978, 207, 101-108.
6. Pöyhiä, R.; Seppälä, T.; Olkkola, K.T.; Kalso, E. The pharmacokinetics and metabolism of oxycodone after intramuscular and oral administration to healthy subjects. J. Clin. Pharmac. 1992, 33, 617-621.
7. Kaiko, R.F.; Benziger, D.P.; Fitzmartin, R.D.; Burke, B.E.; Reder, R.F.; Goldenheim, P.D. Pharmacokinetic-pharmacodynamic relationships of controlled-release oxycodone. Clin. Pharmacol. Ther. 1996, 59, 52-61.
8. Wey, A.B.; Thormann, W. Capillary electrophoresis and capillary electrophoresis-ion trap multiple-stage mass spectrometry for the differentiation and identification of oxycodone and its major metabolites in human urine. J. Chromatogr. B 2002, 770, 191-205.
9. Smith, M.T.; Watt, J.A.; Mapp, G.P.; Cramond, T. Quantitation of oxycodone in human plasma using high-performance liquid chromatography with electrochemical detection. Ther. Drug Monit. 1991, 13, 126-130.
10. Wright, A.W.E.; Lawrence, J.A.; Iu, M.; Cramond, T.; Smith, M.T. Solid-phase extraction method with high-performance liquid chromatography and electrochemical detection for the quantitative analysis of oxycodone in human plasma. J. Chromatogr. B 1998, 712, 169-175.
11. Caufield, W.V.; Stewart, J.T. Rapid determination of selected drugs of abuse in human plasma using a monolithic silica HPLC column and solid phase extraction. J. Liq. Chromatogr. Relat. Technol. 2002, 25, 2977-2998.
12. Kapil, R.P.; Padovani, P.K.; King, S.P.; Lam, G.N. Nanogram level quantitation of oxycodone in human plasma by capillary gas chromatography using nitrogenphosphorus selective detection. J. Chromatogr. 1992, 577, 283-287.
13. Ropero-Miller, J.D.; Lambing, M.K.; Winecker, R.E. Simultaneous quantitation of opioids in blood by GC-EI-MS analysis following deproteination, detautomerization of keto analytes, solid-phase extraction, and trimethylsilyl derivatization. J. Anal. Toxicol. 2002, 26, 524-528.
14. Dawson, M.; Fryirs, B.; Kelly, T.; Keegan, J.; Mather, L.E. A rapid and sensitive high-performance liquid chromatography-electrospray ionization-triple quadrupole mass spectrometry method for the quantitation of oxycodone in human plasma. J. Chromatgr. Sci. 2002, 40, 40-44.
15. Knight, A.W.; Greenway, G.M. Relationship between structural attributes and observed electrogenerated chemiluminescence (ECL) activity of tertiary amines as potential analytes for the tris(2,2-bipyridine)ruthenium (II) ECL. Analyst 1996, 121, 101R-106R.
16. Knight, A.W. A review of recent trends in analytical applications of electrogenerated chemiluminescence. Trends Anal. Chem. 1999, 18, 47-62.
17. Gemba, Y.; Hashimoto, H.; Konishi, M. Simultaneous determination of oxycodone and noroxycodone in dog plasma and urine by HPLC, with post-column chemiluminescence detection using electrogenerated tris(2,2′-bipyridyl) ruthenium (III). J. Liq. Chromatogr. Relat. Technol. 2004, 27, 843-862.
18. Broglé, K.; Ornaf, R.M.; Wu, D.; Palermo, P.J. Peak fronting in reversed-phase high-performance liquid chromatography: a study of the chromatographic behavior of oxycodone hydrochloride. J. Pharm. Biomed. Anal. 1999, 19, 669-678.